Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRILACICLIB for Infection prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where TRILACICLIB was used for Infection prophylaxis.

Most Reported Side Effects for TRILACICLIB

Side Effect Reports % Deaths Hosp.
Off label use 25 11.1% 0 1
Myelosuppression 24 10.6% 2 20
Dyspnoea 18 8.0% 1 13
Pneumonia 18 8.0% 4 17
White blood cell count decreased 18 8.0% 1 14
Platelet count decreased 17 7.5% 1 16
Anaemia 15 6.6% 2 15
Performance status decreased 14 6.2% 0 14
Death 13 5.8% 13 1
Infection 12 5.3% 0 11
Haemorrhage 11 4.9% 0 11
Red blood cell count decreased 11 4.9% 0 10
Sepsis 11 4.9% 1 11
Chest discomfort 10 4.4% 0 9
Cough 10 4.4% 1 9

Other Indications for TRILACICLIB

Product used for unknown indication (92) Myelosuppression (57) Small cell lung cancer (20) Small cell lung cancer extensive stage (13) Bone marrow failure (7) Lung neoplasm malignant (7)

Other Drugs Used for Infection prophylaxis

SULFAMETHOXAZOLE\TRIMETHOPRIM (1,215) VALACYCLOVIR (704) CHLORHEXIDINE\ISOPROPYL ALCOHOL (670) ACYCLOVIR (317) LEVOFLOXACIN (273) CHLORHEXIDINE (248) CIPROFLOXACIN (218) MESNA (204) ALCOHOL (202) FLUCONAZOLE (194)

Related Pages

TRILACICLIB Full Profile All Infection prophylaxis Drugs TRILACICLIB Demographics TRILACICLIB Timeline